Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any left ventricular noncompaction in which the cause of the disease is a mutation in the MYBPC3 gene.
Features include always present findings: Left ventricular noncompaction; and sometimes findings: Congestive heart failure, High blood pressure in lung arteries (pulmonary arterial hypertension), Increased left ventricular end-diastolic volume, and Syncope. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 5 | Left ventricular noncompaction, Congestive heart failure, High blood pressure in lung arteries (pulmonary arterial hypertension) |
MYBPC3 encodes myosin binding protein C3 (1,274 aa). Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. Highest expression in Heart Left Ventricle (1,351 TPM) and Heart Atrial Appendage (991.7 TPM).
Left ventricular noncompaction 10 is associated with mutations in the MYBPC3 gene on chromosome 11.
MYBPC3 is classified as a druggable target (Kinase category) with score 6.5.
Genetic testing for MYBPC3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for left ventricular noncompaction 10 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for left ventricular noncompaction 10.
38 publications have been identified in PubMed for left ventricular noncompaction 10. Research spans Case Report / Case Series (26%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 26% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lungs and breathing | 1 | High blood pressure in lung arteries (pulmonary arterial hypertension) |
Laboratory research
9 |
24% |
Disease patterns and progression | 6 | 16% |
Testing and diagnosis research | 5 | 13% |
Research summaries | 4 | 11% |
Clinical study results | 3 | 8% |
Other research | 1 | 3% |
Jiang J (2026). [PMID: 41580760](https://pubmed.ncbi.nlm.nih.gov/41580760/). *J Transl Med*. [Diagnostic / Biomarker]
Kurt H (2026). [PMID: 41728227](https://pubmed.ncbi.nlm.nih.gov/41728227/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Aranzazu-Ceballos AD (2026). [PMID: 41766641](https://pubmed.ncbi.nlm.nih.gov/41766641/). *Cardiol Young*. [Epidemiology / Natural History]
Zhou Y (2026). [PMID: 41878144](https://pubmed.ncbi.nlm.nih.gov/41878144/). *Open Life Sci*. [Case Report / Case Series]
Chen Y (2026). [PMID: 41918692](https://pubmed.ncbi.nlm.nih.gov/41918692/). *Front Pediatr*. [Diagnostic / Biomarker]
Zhang Y (2026). [PMID: 41727761](https://pubmed.ncbi.nlm.nih.gov/41727761/). *Front Pediatr*. [Case Report / Case Series]
Nusrat A (2026). [PMID: 41477684](https://pubmed.ncbi.nlm.nih.gov/41477684/). *Circ Heart Fail*. [Basic Science / Preclinical]
Martínez-Tittonel LE (2025). [PMID: 41149846](https://pubmed.ncbi.nlm.nih.gov/41149846/). *J Pers Med*. [Review / Meta-Analysis]
Cerar A (2025). [PMID: 41301866](https://pubmed.ncbi.nlm.nih.gov/41301866/). *Biomedicines*. [Epidemiology / Natural History]
Zhang Z (2025). [PMID: 40634327](https://pubmed.ncbi.nlm.nih.gov/40634327/). *Sci Data*. [Basic Science / Preclinical]